Fibroblast growth factor (FGF) signaling in development and skeletal diseases

Genes and Diseases

Volumn 1, Issue 2, 2014, Pages 199-213

  Teven, Chad M ^a   Farina, Evan M ^b   Rivas, Jane ^b   Reid, Russell R ^a  

^a UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

Craniosynostosis; FGF signaling; Fibroblast growth factor; Fibroblast growth factor receptor; Genetics; Pathogenesis; Signal transduction; Skeletal development

Indexed keywords

FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ACHONDROPLASIA; ACROCEPHALOSYNDACTYLY; BEARE STEVENSON CUTIS GYRATA SYNDROME; BONE DISEASE; CARCINOGENESIS; CELL DIFFERENTIATION; CELL FUNCTION; CELL MIGRATION; CELL PROLIFERATION; CRANIAL SUTURE; CRANIOFACIAL SYNOSTOSIS; CROUZON SYNDROME; DEVELOPMENT; EMBRYO DEVELOPMENT; HOMEOSTASIS; HUMAN; HYPOCHONDROPLASIA; JACKSON WEISS SYNDROME; MORPHOGENESIS; MUENKE SYNDROME; NONSYNDROMIC CRANIOSYNOSTOSIS; OSSIFICATION; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION; SKELETON MALFORMATION; SKULL; SKULL MALFORMATION; THANATOPHORIC DWARFISM; TISSUE REPAIR;

EID: 84978085683     PISSN: None     EISSN: 23523042     Source Type: Journal    
DOI: 10.1016/j.gendis.2014.09.005     Document Type: Review

References (201)

1. Ornitz D.M., Itoh N. Fibroblast growth factors. Genome Biol 2001, 2. REVIEWS3005.
2. Repair and Grafting of Bone. Plastic Surgery 2012, vol. 1. Elsevier Saunders, Philadelphia, PA, [Priciples]. I.A. Seitz, C.M. Teven, R.R. Reid (Eds.).
3. Thisse B., Thisse C. Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol Nov 15 2005, 287:390-402.
4. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat Rev Drug Discov Mar 2009, 8:235-253.
5. Itoh N., Ornitz D.M. Evolution of the Fgf and Fgfr gene families. Trends Genet Nov 2004, 20:563-569.
6. Lee P.L., Johnson D.E., Cousens L.S., Fried V.A., Williams L.T. Purification and complementary DNA cloning of a receptor for basic fibroblast growth factor. Science Jul 7 1989, 245:57-60.
7. Johnson D.E., Lee P.L., Lu J., Williams L.T. Diverse forms of a receptor for acidic and basic fibroblast growth factors. Mol Cell Biol Sep 1990, 10:4728-4736.
8. Passos-Bueno M.R., Wilcox W.R., Jabs E.W., Sertie A.L., Alonso L.G., Kitoh H. Clinical spectrum of fibroblast growth factor receptor mutations. Hum Mutat 1999, 14:115-125.
9. Wang F., Kan M., Yan G., Xu J., McKeehan W.L. Alternately spliced NH2-terminal immunoglobulin-like Loop I in the ectodomain of the fibroblast growth factor (FGF) receptor 1 lowers affinity for both heparin and FGF-1. J Biol Chem Apr 28 1995, 270:10231-10235.
10. Zhang X., Ibrahimi O.A., Olsen S.K., Umemori H., Mohammadi M., Ornitz D.M. Receptor specificity of the fibroblast growth factor family. The complete mammalian FGF family. J Biol Chem Jun 9 2006, 281:15694-15700.
11. De Moerlooze L., Spencer-Dene B., Revest J.M., Hajihosseini M., Rosewell I., Dickson C. An important role for the IIIb isoform of fibroblast growth factor receptor 2 (FGFR2) in mesenchymal-epithelial signalling during mouse organogenesis. Development Feb 2000, 127:483-492.
12. Turner N., Grose R. Fibroblast growth factor signalling: from development to cancer. Nat Rev Cancer Feb 2010, 10:116-129.
13. Kan S.H., Elanko N., Johnson D., et al. Genomic screening of fibroblast growth-factor receptor 2 reveals a wide spectrum of mutations in patients with syndromic craniosynostosis. Am J Hum Genet Feb 2002, 70:472-486.
14. Tekin M., Hismi B.O., Fitoz S., et al. Homozygous mutations in fibroblast growth factor 3 are associated with a new form of syndromic deafness characterized by inner ear agenesis, microtia, and microdontia. Am J Hum Genet Feb 2007, 80:338-344.
15. Rohmann E., Brunner H.G., Kayserili H., et al. Mutations in different components of FGF signaling in LADD syndrome. Nat Genet Apr 2006, 38:414-417.
16. Spielberger R., Stiff P., Bensinger W., et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med Dec 16 2004, 351:2590-2598.
17. Wesche J., Haglund K., Haugsten E.M. Fibroblast growth factors and their receptors in cancer. Biochem J Jul 15 2011, 437:199-213.
18. Mohammadi M., Dikic I., Sorokin A., Burgess W.H., Jaye M., Schlessinger J. Identification of six novel autophosphorylation sites on fibroblast growth factor receptor 1 and elucidation of their importance in receptor activation and signal transduction. Mol Cell Biol Mar 1996, 16:977-989.
19. Mohammadi M., Honegger A.M., Rotin D., et al. A tyrosine-phosphorylated carboxy-terminal peptide of the fibroblast growth factor receptor (Flg) is a binding site for the SH2 domain of phospholipase C-gamma 1. Mol Cell Biol Oct 1991, 11:5068-5078.
20. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev Apr 2005, 16:139-149.
21. Yun Y.R., Won J.E., Jeon E., et al. Fibroblast growth factors: biology, function, and application for tissue regeneration. J Tissue Eng 2010, 2010:218142.
22. Dorey K., Amaya E. FGF signalling: diverse roles during early vertebrate embryogenesis. Development Nov 2010, 137:3731-3742.
23. Shao D., Lazar M.A. Modulating nuclear receptor function: may the phos be with you. J Clin Invest Jun 1999, 103:1617-1618.
24. Wong A., Lamothe B., Lee A., Schlessinger J., Lax I. FRS2 alpha attenuates FGF receptor signaling by Grb2-mediated recruitment of the ubiquitin ligase Cbl. Proc Natl Acad Sci U S A May 14 2002, 99:6684-6689.
25. Lax I., Wong A., Lamothe B., et al. The docking protein FRS2 alpha controls a MAP kinase-mediated negative feedback mechanism for signaling by FGF receptors. Mol Cell Oct 2002, 10:709-719.
26. Dailey L., Ambrosetti D., Mansukhani A., Basilico C. Mechanisms underlying differential responses to FGF signaling. Cytokine Growth Factor Rev Apr 2005, 16:233-247.
27. Lamothe B., Yamada M., Schaeper U., Birchmeier W., Lax I., Schlessinger J. The docking protein Gab1 is an essential component of an indirect mechanism for fibroblast growth factor stimulation of the phosphatidylinositol 3-kinase/Akt antiapoptotic pathway. Mol Cell Biol Jul 2004, 24:5657-5666.
28. Schlessinger J. Cell signaling by receptor tyrosine kinases. Cell Oct 13 2000, 103:211-225.
29. Katoh M. FGF signaling network in the gastrointestinal tract (review). Int J Oncol Jul 2006, 29:163-168.
30. Hacohen N., Kramer S., Sutherland D., Hiromi Y., Krasnow M.A. Sprouty encodes a novel antagonist of FGF signaling that patterns apical branching of the Drosophila airways. Cell Jan 23 1998, 92:253-263.
31. Casci T., Vinos J., Freeman M. Sprouty, an intracellular inhibitor of Ras signaling. Cell Mar 5 1999, 96:655-665.
32. Zhao Y., Zhang Z.Y. The mechanism of dephosphorylation of extracellular signal-regulated kinase 2 by mitogen-activated protein kinase phosphatase 3. J Biol Chem Aug 24 2001, 276:32382-32391.
33. Furthauer M., Lin W., Ang S.L., Thisse B., Thisse C. Sef is a feedback-induced antagonist of Ras/MAPK-mediated FGF signalling. Nat Cell Biol Feb 2002, 4:170-174.
34. Tsang M., Dawid I.B. Promotion and attenuation of FGF signaling through the Ras-MAPK pathway. Sci STKE Apr 13 2004, 2004:pe17.
35. Thien C.B., Langdon W.Y. Cbl: many adaptations to regulate protein tyrosine kinases. Nat Rev Mol Cell Biol Apr 2001, 2:294-307.
36. Pownall M.E., Isaacs H.V. FGF Signalling in Vertebrate Development. Developmental Biology 2010, Morgan & Claypool Life Sciences, San Rafael, CA.
37. Ciruna B., Rossant J. FGF signaling regulates mesoderm cell fate specification and morphogenetic movement at the primitive streak. Dev Cell Jul 2001, 1:37-49.
38. Ciruna B.G., Schwartz L., Harpal K., Yamaguchi T.P., Rossant J. Chimeric analysis of fibroblast growth factor receptor-1 (Fgfr1) function: a role for FGFR1 in morphogenetic movement through the primitive streak. Development Jul 1997, 124:2829-2841.
39. Sun X., Meyers E.N., Lewandoski M., Martin G.R. Targeted disruption of Fgf8 causes failure of cell migration in the gastrulating mouse embryo. Genes Dev Jul 15 1999, 13:1834-1846.
40. Sekine K., Ohuchi H., Fujiwara M., et al. Fgf10 is essential for limb and lung formation. Nat Genet Jan 1999, 21:138-141.
41. Sun X., Mariani F.V., Martin G.R. Functions of FGF signalling from the apical ectodermal ridge in limb development. Nature Aug 1 2002, 418:501-508.
42. Gomez-Pinilla F., Cotman C.W. Distribution of fibroblast growth factor 5 mRNA in the rat brain: an in situ hybridization study. Brain Res Mar 19 1993, 606:79-86.
43. Hattori Y., Miyake A., Mikami T., Ohta M., Itoh N. Transient expression of FGF-5 mRNA in the rat cerebellar cortex during post-natal development. Brain Res Mol Brain Res Jul 1997, 47:262-266.
44. Hattori Y., Yamasaki M., Konishi M., Itoh N. Spatially restricted expression of fibroblast growth factor-10 mRNA in the rat brain. Brain Res Mol Brain Res Jul 1997, 47:139-146.
45. Smallwood P.M., Munoz-Sanjuan I., Tong P., et al. Fibroblast growth factor (FGF) homologous factors: new members of the FGF family implicated in nervous system development. Proc Natl Acad Sci U S A Sep 3 1996, 93:9850-9857.
46. Stock A., Kuzis K., Woodward W.R., Nishi R., Eckenstein F.P. Localization of acidic fibroblast growth factor in specific subcortical neuronal populations. J Neurosci Dec 1992, 12:4688-4700.
47. Woodward W.R., Nishi R., Meshul C.K., Williams T.E., Coulombe M., Eckenstein F.P. Nuclear and cytoplasmic localization of basic fibroblast growth factor in astrocytes and CA2 hippocampal neurons. J Neurosci Jan 1992, 12:142-152.
48. Yamashita T., Yoshioka M., Itoh N. Identification of a novel fibroblast growth factor, FGF-23, preferentially expressed in the ventrolateral thalamic nucleus of the brain. Biochem Biophys Res Commun Oct 22 2000, 277:494-498.
49. Dono R. Fibroblast growth factors as regulators of central nervous system development and function. Am J Physiol Regul Integr Comp Physiol Apr 2003, 284:R867-R881.
50. Yang X., Dormann D., Munsterberg A.E., Weijer C.J. Cell movement patterns during gastrulation in the chick are controlled by positive and negative chemotaxis mediated by FGF4 and FGF8. Dev Cell Sep 2002, 3:425-437.
51. Kubota Y., Ito K. Chemotactic migration of mesencephalic neural crest cells in the mouse. Dev Dyn Feb 2000, 217:170-179.
52. Wilson R., Leptin M. Fibroblast growth factor receptor-dependent morphogenesis of the Drosophila mesoderm. Philos Trans R Soc Lond B Biol Sci Jul 29 2000, 355:891-895.
53. Montell D.J. The genetics of cell migration in Drosophila melanogaster and Caenorhabditis elegans development. Development Jun 1999, 126:3035-3046.
54. Bottcher R.T., Niehrs C. Fibroblast growth factor signaling during early vertebrate development. Endocr Rev Feb 2005, 26:63-77.
55. Coumoul X., Deng C.X. Roles of FGF receptors in mammalian development and congenital diseases. Birth Defects Res C Embryo Today Nov 2003, 69:286-304.
56. Nutt S.L., Dingwell K.S., Holt C.E., Amaya E. Xenopus Sprouty2 inhibits FGF-mediated gastrulation movements but does not affect mesoderm induction and patterning. Genes Dev May 1 2001, 15:1152-1166.
57. Deng C.X., Wynshaw-Boris A., Shen M.M., Daugherty C., Ornitz D.M., Leder P. Murine FGFR-1 is required for early postimplantation growth and axial organization. Genes Dev Dec 15 1994, 8:3045-3057.
58. Yamaguchi T.P., Harpal K., Henkemeyer M., Rossant J. fgfr-1 is required for embryonic growth and mesodermal patterning during mouse gastrulation. Genes Dev Dec 15 1994, 8:3032-3044.
59. Deng C., Bedford M., Li C., et al. Fibroblast growth factor receptor-1 (FGFR-1) is essential for normal neural tube and limb development. Dev Biol May 1 1997, 185:42-54.
60. Meyers E.N., Martin G.R. Differences in left-right axis pathways in mouse and chick: functions of FGF8 and SHH. Science Jul 16 1999, 285:403-406.
61. Mizoguchi T., Izawa T., Kuroiwa A., Kikuchi Y. Fgf signaling negatively regulates Nodal-dependent endoderm induction in zebrafish. Dev Biol Dec 15 2006, 300:612-622.
62. Nentwich O., Dingwell K.S., Nordheim A., Smith J.C. Downstream of FGF during mesoderm formation in Xenopus: the roles of Elk-1 and Egr-1. Dev Biol Dec 15 2009, 336:313-326.
63. Kimelman D., Griffin K.J. Vertebrate mesendoderm induction and patterning. Curr Opin Genet Dev Aug 2000, 10:350-356.
64. Slack J.M., Darlington B.G., Heath J.K., Godsave S.F. Mesoderm induction in early Xenopus embryos by heparin-binding growth factors. Nature Mar 12-18 1987, 326:197-200.
65. Cornell R.A., Kimelman D. Activin-mediated mesoderm induction requires FGF. Development Feb 1994, 120:453-462.
66. Fletcher R.B., Harland R.M. The role of FGF signaling in the establishment and maintenance of mesodermal gene expression in Xenopus. Dev Dyn May 2008, 237:1243-1254.
67. Amaya E., Musci T.J., Kirschner M.W. Expression of a dominant negative mutant of the FGF receptor disrupts mesoderm formation in Xenopus embryos. Cell Jul 26 1991, 66:257-270.
68. Wilson P.A., Hemmati-Brivanlou A. Vertebrate neural induction: inducers, inhibitors, and a new synthesis. Neuron May 1997, 18:699-710.
69. Wilson S.I., Edlund T. Neural induction: toward a unifying mechanism. Nat Neurosci Nov 2001, (4 suppl):1161-1168.
70. Marchal L., Luxardi G., Thome V., Kodjabachian L. BMP inhibition initiates neural induction via FGF signaling and Zic genes. Proc Natl Acad Sci U S A Oct 13 2009, 106:17437-17442.
71. Christofori G. Split personalities: the agonistic antagonist Sprouty. Nat Cell Biol May 2003, 5:377-379.
72. Pera E.M., Ikeda A., Eivers E., De Robertis E.M. Integration of IGF, FGF, and anti-BMP signals via Smad1 phosphorylation in neural induction. Genes Dev Dec 15 2003, 17:3023-3028.
73. Branney P.A., Faas L., Steane S.E., Pownall M.E., Isaacs H.V. Characterisation of the fibroblast growth factor dependent transcriptome in early development. PLoS One 2009, 4:e4951.
74. Delaune E., Lemaire P., Kodjabachian L. Neural induction in Xenopus requires early FGF signalling in addition to BMP inhibition. Development Jan 2005, 132:299-310.
75. Pownall M.E., Isaacs H.V., Slack J.M. Two phases of Hox gene regulation during early Xenopus development. Curr Biol May 21 1998, 8:673-676.
76. Doniach T. Basic FGF as an inducer of anteroposterior neural pattern. Cell Dec 29 1995, 83:1067-1070.
77. Umbhauer M., Penzo-Mendez A., Clavilier L., Boucaut J., Riou J. Signaling specificities of fibroblast growth factor receptors in early Xenopus embryo. J Cell Sci Aug 2000, 113(Pt 16):2865-2875.
78. Lamb T.M., Harland R.M. Fibroblast growth factor is a direct neural inducer, which combined with noggin generates anterior-posterior neural pattern. Development Nov 1995, 121:3627-3636.
79. Ribisi S., Mariani F.V., Aamar E., Lamb T.M., Frank D., Harland R.M. Ras-mediated FGF signaling is required for the formation of posterior but not anterior neural tissue in Xenopus laevis. Dev Biol Nov 1 2000, 227:183-196.
80. Holowacz T., Sokol S. FGF is required for posterior neural patterning but not for neural induction. Dev Biol Jan 15 1999, 205:296-308.
81. Cox W.G., Hemmati-Brivanlou A. Caudalization of neural fate by tissue recombination and bFGF. Development Dec 1995, 121:4349-4358.
82. Sato T., Joyner A.L., Nakamura H. How does Fgf signaling from the isthmic organizer induce midbrain and cerebellum development?. Dev Growth Differ Dec 2004, 46:487-494.
83. Sato T., Nakamura H. The Fgf8 signal causes cerebellar differentiation by activating the Ras-ERK signaling pathway. Development Sep 2004, 131:4275-4285.
84. Suzuki-Hirano A., Sato T., Nakamura H. Regulation of isthmic Fgf8 signal by sprouty2. Development Jan 2005, 132:257-265.
85. Crossley P.H., Martinez S., Martin G.R. Midbrain development induced by FGF8 in the chick embryo. Nature Mar 7 1996, 380:66-68.
86. Pearson J.C., Lemons D., McGinnis W. Modulating Hox gene functions during animal body patterning. Nat Rev Genet Dec 2005, 6:893-904.
87. Pownall M.E., Tucker A.S., Slack J.M., Isaacs H.V. eFGF, Xcad3 and Hox genes form a molecular pathway that establishes the anteroposterior axis in Xenopus. Development Dec 1996, 122:3881-3892.
88. Cho K.W., De Robertis E.M. Differential activation of Xenopus homeo box genes by mesoderm-inducing growth factors and retinoic acid. Genes Dev Nov 1990, 4:1910-1916.
89. Kolm P.J., Sive H.L. Regulation of the Xenopus labial homeodomain genes, HoxA1 and HoxD1: activation by retinoids and peptide growth factors. Dev Biol Jan 1995, 167:34-49.
90. Partanen J., Schwartz L., Rossant J. Opposite phenotypes of hypomorphic and Y766 phosphorylation site mutations reveal a function for Fgfr1 in anteroposterior patterning of mouse embryos. Genes Dev Aug 1 1998, 12:2332-2344.
91. Bel-Vialar S., Itasaki N., Krumlauf R. Initiating Hox gene expression: in the early chick neural tube differential sensitivity to FGF and RA signaling subdivides the HoxB genes in two distinct groups. Development Nov 2002, 129:5103-5115.
92. Isaacs H.V., Pownall M.E., Slack J.M. Regulation of Hox gene expression and posterior development by the Xenopus caudal homologue Xcad3. EMBO J Jun 15 1998, 17:3413-3427.
93. Isaacs H.V., Pownall M.E., Slack J.M. eFGF regulates Xbra expression during Xenopus gastrulation. EMBO J Oct 3 1994, 13:4469-4481.
94. Keenan I.D., Sharrard R.M., Isaacs H.V. FGF signal transduction and the regulation of Cdx gene expression. Dev Biol Nov 15 2006, 299:478-488.
95. Northrop J.L., Kimelman D. Dorsal-ventral differences in Xcad-3 expression in response to FGF-mediated induction in Xenopus. Dev Biol Feb 1994, 161:490-503.
96. Faas L., Isaacs H.V. Overlapping functions of Cdx1, Cdx2, and Cdx4 in the development of the amphibian Xenopus tropicalis. Dev Dyn Apr 2009, 238:835-852.
97. Godsave S.F., Durston A.J. Neural induction and patterning in embryos deficient in FGF signaling. Int J Dev Biol Feb 1997, 41:57-65.
98. Niswander L., Martin G.R. Fgf-4 expression during gastrulation, myogenesis, limb and tooth development in the mouse. Development Mar 1992, 114:755-768.
99. Martin G.R. The roles of FGFs in the early development of vertebrate limbs. Genes Dev Jun 1 1998, 12:1571-1586.
100. Tickle C., Munsterberg A. Vertebrate limb development - the early stages in chick and mouse. Curr Opin Genet Dev Aug 2001, 11:476-481.
101. Xu X., Weinstein M., Li C., et al. Fibroblast growth factor receptor 2 (FGFR2)-mediated reciprocal regulation loop between FGF8 and FGF10 is essential for limb induction. Development Feb 1998, 125:753-765.
102. Ohuchi H., Nakagawa T., Yamamoto A., et al. The mesenchymal factor, FGF10, initiates and maintains the outgrowth of the chick limb bud through interaction with FGF8, an apical ectodermal factor. Development Jun 1997, 124:2235-2244.
103. Mahmood R., Bresnick J., Hornbruch A., et al. A role for FGF-8 in the initiation and maintenance of vertebrate limb bud outgrowth. Curr Biol Jul 1 1995, 5:797-806.
104. Vogel A., Rodriguez C., Izpisua-Belmonte J.C. Involvement of FGF-8 in initiation, outgrowth and patterning of the vertebrate limb. Development Jun 1996, 122:1737-1750.
105. Crossley P.H., Minowada G., MacArthur C.A., Martin G.R. Roles for FGF8 in the induction, initiation, and maintenance of chick limb development. Cell Jan 12 1996, 84:127-136.
106. Ros M.A., Lopez-Martinez A., Simandl B.K., et al. The limb field mesoderm determines initial limb bud anteroposterior asymmetry and budding independent of sonic hedgehog or apical ectodermal gene expressions. Development Aug 1996, 122:2319-2330.
107. Goldfarb M. Functions of fibroblast growth factors in vertebrate development. Cytokine Growth Factor Rev Dec 1996, 7:311-325.
108. Yu K., Ornitz D.M. FGF signaling regulates mesenchymal differentiation and skeletal patterning along the limb bud proximodistal axis. Development Feb 2008, 135:483-491.
109. Nie X., Luukko K., Kettunen P. FGF signalling in craniofacial development and developmental disorders. Oral Dis Mar 2006, 12:102-111.
110. Morriss-Kay G.M., Iseki S., Johnson D. Genetic control of the cell proliferation-differentiation balance in the developing skull vault: roles of fibroblast growth factor receptor signalling pathways. Novartis Found Symp 2001, 232:102-116. discussion 116-121.
111. Hatch N.E. FGF signaling in craniofacial biological control and pathological craniofacial development. Crit Rev Eukaryot Gene Expr 2010, 20:295-311.
112. Wilkie A.O. Craniosynostosis: genes and mechanisms. Hum Mol Genet 1997, 6:1647-1656.
113. Nuckolls G.H., Shum L., Slavkin H.C. Progress toward understanding craniofacial malformations. Cleft Palate Craniofac J Jan 1999, 36:12-26.
114. Marie P.J., Debiais F., Hay E. Regulation of human cranial osteoblast phenotype by FGF-2, FGFR-2 and BMP-2 signaling. Histol Histopathol 2002, 17:877-885.
115. Kim H.J., Rice D.P., Kettunen P.J., Thesleff I.F.G.F.- BMP- and Shh-mediated signalling pathways in the regulation of cranial suture morphogenesis and calvarial bone development. Development Apr 1998, 125:1241-1251.
116. Rice D.P., Aberg T., Chan Y., et al. Integration of FGF and TWIST in calvarial bone and suture development. Development May 2000, 127:1845-1855.
117. Noden D.M. The role of the neural crest in patterning of avian cranial skeletal, connective, and muscle tissues. Dev Biol Mar 1983, 96:144-165.
118. Noden D.M. Origins and patterning of craniofacial mesenchymal tissues. J Craniofac Genet Dev Biol Suppl 1986, 2:15-31.
119. Schaaf P. Histochemical behavior of Paneth's cells in Central American bat species with varying nutritional habits. Results of the 1st Cuban-German "Alexander-von-Humbolt" expedition 1967-68. 4. Anat Anz 1970, 126:275-277.
120. Couly G.F., Le Douarin N.M. Mapping of the early neural primordium in quail-chick chimeras. II. The prosencephalic neural plate and neural folds: implications for the genesis of cephalic human congenital abnormalities. Dev Bio Mar 1987, 120:198-214.
121. Couly G.F., Coltey P.M., Le Douarin N.M. The developmental fate of the cephalic mesoderm in quail-chick chimeras. Development Jan 1992, 114:1-15.
122. Couly G.F., Coltey P.M., Le Douarin N.M. The triple origin of skull in higher vertebrates: a study in quail-chick chimeras. Development Feb 1993, 117:409-429.
123. Baker C.V., Bronner-Fraser M. The origins of the neural crest. Part I: embryonic induction. Mech Dev Dec 1997, 69:3-11.
124. Villanueva S., Glavic A., Ruiz P., Mayor R. Posteriorization by FGF, Wnt, and retinoic acid is required for neural crest induction. Dev Biol Jan 15 2002, 241:289-301.
125. Monsoro-Burq A.H., Fletcher R.B., Harland R.M. Neural crest induction by paraxial mesoderm in Xenopus embryos requires FGF signals. Development Jul 2003, 130:3111-3124.
126. Monsoro-Burq A.H., Wang E., Harland R. Msx1 and Pax3 cooperate to mediate FGF8 and WNT signals during Xenopus neural crest induction. Dev Cell Feb 2005, 8:167-178.
127. Bachler M., Neubuser A. Expression of members of the Fgf family and their receptors during midfacial development. Mech Dev Feb 2001, 100:313-316.
128. Delezoide A.L., Benoist-Lasselin C., Legeai-Mallet L., et al. Spatio-temporal expression of FGFR 1, 2 and 3 genes during human embryo-fetal ossification. Mech Dev Sep 1998, 77:19-30.
129. Opperman L.A. Cranial sutures as intramembranous bone growth sites. Dev Dyn Dec 2000, 219:472-485.
130. Iseki S., Wilkie A.O., Morriss-Kay G.M. Fgfr1 and Fgfr2 have distinct differentiation- and proliferation-related roles in the developing mouse skull vault. Development Dec 1999, 126:5611-5620.
131. Pritchard J.J., Scott J.H., Girgis F.G. The structure and development of cranial and facial sutures. J Anat Jan 1956, 90:73-86.
132. Opperman L.A., Chhabra A., Nolen A.A., Bao Y., Ogle R.C. Dura mater maintains rat cranial sutures invitro by regulating suture cell proliferation and collagen production. J Craniofac Genet Dev Biol Jul-Sep 1998, 18:150-158.
133. Mehrara B.J., Mackool R.J., McCarthy J.G., Gittes G.K., Longaker M.T. Immunolocalization of basic fibroblast growth factor and fibroblast growth factor receptor-1 and receptor-2 in rat cranial sutures. Plast Reconstr Surg Nov 1998, 102:1805-1817. discussion 1818-1820.
134. Chikazu D., Katagiri M., Ogasawara T., et al. Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J Bone Miner Res Nov 2001, 16:2074-2081.
135. Opperman L.A., Passarelli R.W., Morgan E.P., Reintjes M., Ogle R.C. Cranial sutures require tissue interactions with dura mater to resist osseous obliteration invitro. J Bone Miner Res Dec 1995, 10:1978-1987.
136. Aviezer D., Golembo M., Yayon A. Fibroblast growth factor receptor-3 as a therapeutic target for Achondroplasia - genetic short limbed dwarfism. Curr Drug Targets Jul 2003, 4:353-365.
137. Shiang R., Thompson L.M., Zhu Y.Z., et al. Mutations in the transmembrane domain of FGFR3 cause the most common genetic form of dwarfism, achondroplasia. Cell Jul 29 1994, 78:335-342.
138. Bellus G.A., Hefferon T.W., Ortiz de Luna R.I., et al. Achondroplasia is defined by recurrent G380R mutations of FGFR3. Am J Hum Genet Feb 1995, 56:368-373.
139. Heuertz S., Le Merrer M., Zabel B., et al. Novel FGFR3 mutations creating cysteine residues in the extracellular domain of the receptor cause achondroplasia or severe forms of hypochondroplasia. Eur J Hum Genet Dec 2006, 14:1240-1247.
140. Bonaventure J., Rousseau F., Legeai-Mallet L., Le Merrer M., Munnich A., Maroteaux P. Common mutations in the fibroblast growth factor receptor 3 (FGFR 3) gene account for achondroplasia, hypochondroplasia, and thanatophoric dwarfism. Am J Med Genet May 3 1996, 63:148-154.
141. Cohen M.M. Achondroplasia, hypochondroplasia and thanatophoric dysplasia: clinically related skeletal dysplasias that are also related at the molecular level. Int J Oral Maxillofac Surg Dec 1998, 27:451-455.
142. Bellus G.A., McIntosh I., Smith E.A., et al. A recurrent mutation in the tyrosine kinase domain of fibroblast growth factor receptor 3 causes hypochondroplasia. Nat Genet Jul 1995, 10:357-359.
143. Noe E.J., Yoo H.W., Kim K.N., Lee S.Y. A case of thanatophoric dysplasia type I with an R248C mutation in the FGFR3 gene. Korean J Pediatr Dec 2010, 53:1022-1025.
144. Parker B.C., Engels M., Annala M., Zhang W. Emergence of FGFR family gene fusions as therapeutic targets in a wide spectrum of solid tumours. J Pathol Jan 2014, 232:4-15.
145. Dodurga Y., Tataroglu C., Kesen Z., Satiroglu-Tufan N.L. Incidence of fibroblast growth factor receptor 3 gene (FGFR3) A248C, S249C, G372C, and T375C mutations in bladder cancer. Genet Mol Res 2011, 10:86-95.
146. Pollock P.M., Gartside M.G., Dejeza L.C., et al. Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromes. Oncogene Nov 1 2007, 26:7158-7162.
147. Naski M.C., Ornitz D.M. FGF signaling in skeletal development. Front Biosci 1998, 3:d781-794.
148. Floss T., Arnold H.H., Braun T. A role for FGF-6 in skeletal muscle regeneration. Genes Dev Aug 15 1997, 11:2040-2051.
149. Matsui Y., Yasui N., Kimura T., Tsumaki N., Kawabata H., Ochi T. Genotype phenotype correlation in achondroplasia and hypochondroplasia. J Bone Joint Surg Br Nov 1998, 80:1052-1056.
150. Ireland P.J., Pacey V., Zankl A., Edwards P., Johnston L.M., Savarirayan R. Optimal management of complications associated with achondroplasia. Appl Clin Genet 2014, 7:117-125.
151. Lorget F., Kaci N., Peng J., et al. Evaluation of the therapeutic potential of a CNP analog in a Fgfr3 mouse model recapitulating achondroplasia. Am J Hum Genet Dec 7 2012, 91:1108-1114.
152. Bober M.B., Bellus G.A., Nikkel S.M., Tiller GE. Hypochondroplasia 1993.
153. Karczeski B., Cutting G.R. Thanatophoric Dysplasia 1993.
154. Rousseau F., el Ghouzzi V., Delezoide A.L., et al. Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet Apr 1996, 5:509-512.
155. Tavormina P.L., Rimoin D.L., Cohn D.H., Zhu Y.Z., Shiang R., Wasmuth J.J. Another mutation that results in the substitution of an unpaired cysteine residue in the extracellular domain of FGFR3 in thanatophoric dysplasia type I. Hum Mol Genet Nov 1995, 4:2175-2177.
156. Senarath-Yapa K., Chung M.T., McArdle A., et al. Craniosynostosis: molecular pathways and future pharmacologic therapy. Organogenesis Oct-Dec 2012, 8:103-113.
157. Ursitti F., Fadda T., Papetti L., et al. Evaluation and management of nonsyndromic craniosynostosis. Acta Paediatr Sep 2011, 100:1185-1194.
158. Rice D.P. Craniofacial sutures. Development, disease and treatment. Preface. Front Oral Bio. 2008, 12:xi.
159. Cohen M.M. Craniosynostosis update 1987. Am J Med Genet Suppl 1988, 4:99-148.
160. Anderson J., Burns H.D., Enriquez-Harris P., Wilkie A.O., Heath J.K. Apert syndrome mutations in fibroblast growth factor receptor 2 exhibit increased affinity for FGF ligand. Hum Mol Genet Sep 1998, 7:1475-1483.
161. Robin N.H., Falk M.J., Haldeman-Englert C.R. FGFR-related Craniosynostosis Syndromes 1993.
162. Rossi M., Jones R.L., Norbury G., Bloch-Zupan A., Winter R.M. The appearance of the feet in Pfeiffer syndrome caused by FGFR1 P252R mutation. Clin Dysmorphol Oct 2003, 12:269-274.
163. Cornejo-Roldan L.R., Roessler E., Muenke M. Analysis of the mutational spectrum of the FGFR2 gene in Pfeiffer syndrome. Hum Genet May 1999, 104:425-431.
164. Holmes G., Basilico C. Mesodermal expression of Fgfr2S252W is necessary and sufficient to induce craniosynostosis in a mouse model of Apert syndrome. Dev Biol Aug 15 2012, 368:283-293.
165. Yeh E., Fanganiello R.D., Sunaga D.Y., et al. Novel molecular pathways elicited by mutant FGFR2 may account for brain abnormalities in Apert syndrome. PLoS One 2013, 8:e60439.
166. Rouzier C., Soler C., Hofman P., Brennetot C., Bieth E., Pedeutour F. Ovarian dysgerminoma and Apert syndrome. Pediatr Blood Cancer Mar 2008, 50:696-698.
167. Renier D., Arnaud E., Cinalli G., Sebag G., Zerah M., Marchac D. Prognosis for mental function in Apert's syndrome. J Neurosurg Jul 1996, 85:66-72.
168. Zarate Y.A., Putnam P.E., Saal H.M. Intestinal malrotation in a patient with Pfeiffer syndrome type 2. Cleft Palate Craniofac J Nov 2010, 47:638-641.
169. Ibrahimi O.A., Eliseenkova A.V., Plotnikov A.N., Yu K., Ornitz D.M., Mohammadi M. Structural basis for fibroblast growth factor receptor 2 activation in Apert syndrome. Proc Natl Acad Sci U S A Jun 19 2001, 98:7182-7187.
170. Rutland P., Pulleyn L.J., Reardon W., et al. Identical mutations in the FGFR2 gene cause both Pfeiffer and Crouzon syndrome phenotypes. Nat Genet Feb 1995, 9:173-176.
171. Lapunzina P., Fernandez A., Sanchez Romero J.M., et al. A novel insertion in the FGFR2 gene in a patient with Crouzon phenotype and sacrococcygeal tail. Birth Defects Res A Clin Mol Teratol Jan 2005, 73:61-64.
172. Murdoch-Kinch C.A., Ward R.E. Metacarpophalangeal analysis in Crouzon syndrome: additional evidence for phenotypic convergence with the acrocephalosyndactyly syndromes. Am J Med Genet Nov 28 1997, 73:61-66.
173. Chen L., Deng C.X. Roles of FGF signaling in skeletal development and human genetic diseases. Front Biosci 2005, 10:1961-1976.
174. Roscioli T., Flanagan S., Mortimore R.J., et al. Premature calvarial synostosis and epidermal hyperplasia (Beare-Stevenson syndrome-like anomalies) resulting from a P250R missense mutation in the gene encoding fibroblast growth factor receptor 3. Am J Med Genet Jul 1 2001, 101:187-194.
175. Percival C.J., Wang Y., Zhou X., Jabs E.W., Richtsmeier J.T. The effect of a Beare-Stevenson syndrome Fgfr2 Y394C mutation on early craniofacial bone volume and relative bone mineral density in mice. J Anat Nov 2012, 221:434-442.
176. Tartaglia M., Di Rocco C., Lajeunie E., Valeri S., Velardi F., Battaglia P.A. Jackson-Weiss syndrome: identification of two novel FGFR2 missense mutations shared with Crouzon and Pfeiffer craniosynostotic disorders. Hum Genet Nov 1997, 101:47-50.
177. Honnebier M.B., Cabiling D.S., Hetlinger M., McDonald-McGinn D.M., Zackai E.H., Bartlett S.P. The natural history of patients treated for FGFR3-associated (Muenke-type) craniosynostosis. Plast Reconstr Surg Mar 2008, 121:919-931.
178. Barbosa M., Almeida Mdo R., Reis-Lima M., Pinto-Basto J., dos Santos H.G. Muenke syndrome with osteochondroma. Am J Med Genet A Feb 2009, 149A:260-261.
179. David L., Glazier S., Pyle J., Thompson J., Argenta L. Classification system for sagittal craniosynostosis. J Craniofac Surg Mar 2009, 20:279-282.
180. Hunenko O., Karmacharya J., Ong G., Kirschner R.E. Toward an understanding of nonsyndromic craniosynostosis: altered patterns of TGF-beta receptor and FGF receptor expression induced by intrauterine head constraint. Ann Plast Surg May 2001, 46:546-553. discussion 553-544.
181. Meyer A.N., McAndrew C.W., Donoghue D.J. Nordihydroguaiaretic acid inhibits an activated fibroblast growth factor receptor 3 mutant and blocks downstream signaling in multiple myeloma cells. Cancer Res Sep 15 2008, 68:7362-7370.
182. Grand E.K., Chase A.J., Heath C., Rahemtulla A., Cross N.C. Targeting FGFR3 in multiple myeloma: inhibition of t(4;14)-positive cells by SU5402 and PD173074. Leukemia May 2004, 18:962-966.
183. Byron S.A., Gartside M.G., Wellens C.L., et al. Inhibition of activated fibroblast growth factor receptor 2 in endometrial cancer cells induces cell death despite PTEN abrogation. Cancer Res Sep 1 2008, 68:6902-6907.
184. Chow L.Q., Eckhardt S.G. Sunitinib: from rational design to clinical efficacy. J Clin Oncol Mar 1 2007, 25:884-896.
185. Cross N.C., Reiter A. Fibroblast growth factor receptor and platelet-derived growth factor receptor abnormalities in eosinophilic myeloproliferative disorders. Acta Haematol 2008, 119:199-206.
186. Roumiantsev S., Krause D.S., Neumann C.A., et al. Distinct stem cell myeloproliferative/T lymphoma syndromes induced by ZNF198-FGFR1 and BCR-FGFR1 fusion genes from 8p11 translocations. Cancer Cell Mar 2004, 5:287-298.
187. Ohbayashi N., Shibayama M., Kurotaki Y., et al. FGF18 is required for normal cell proliferation and differentiation during osteogenesis and chondrogenesis. Genes Dev Apr 1 2002, 16:870-879.
188. Liu Z., Xu J., Colvin J.S., Ornitz D.M. Coordination of chondrogenesis and osteogenesis by fibroblast growth factor 18. Genes Dev Apr 1 2002, 16:859-869.
189. Ellsworth J.L., Berry J., Bukowski T., et al. Fibroblast growth factor-18 is a trophic factor for mature chondrocytes and their progenitors. Osteoarthr Cartilage Apr 2002, 10:308-320.
190. Moore E.E., Bendele A.M., Thompson D.L., et al. Fibroblast growth factor-18 stimulates chondrogenesis and cartilage repair in a rat model of injury-induced osteoarthritis. Osteoarthr Cartilage Jul 2005, 13:623-631.
191. Cheng H., Liao K.K., Liao S.F., Chuang T.Y., Shih Y.H. Spinal cord repair with acidic fibroblast growth factor as a treatment for a patient with chronic paraplegia. Spine (Phila Pa 1976) Jul 15 2004, 29:E284-E288.
192. Schumacher B., Pecher P., von Specht B.U., Stegmann T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: first clinical results of a new treatment of coronary heart disease. Circulation Feb 24 1998, 97:645-650.
193. Ruel M., Laham R.J., Parker J.A., et al. Long-term effects of surgical angiogenic therapy with fibroblast growth factor 2 protein. J Thorac Cardiovasc Surg Jul 2002, 124:28-34.
194. Henry T.D., Grines C.L., Watkins M.W., et al. Effects of Ad5FGF-4 in patients with angina: an analysis of pooled data from the AGENT-3 and AGENT-4 trials. J Am Coll Cardiol Sep 11 2007, 50:1038-1046.
195. Turner C.A., Gula E.L., Taylor L.P., Watson S.J., Akil H. Antidepressant-like effects of intracerebroventricular FGF2 in rats. Brain Res Aug 11 2008, 1224:63-68.
196. Werner S. Keratinocyte growth factor: a unique player in epithelial repair processes. Cytokine Growth Factor Rev Jun 1998, 9:153-165.
197. Fu L., John L.M., Adams S.H., et al. Fibroblast growth factor 19 increases metabolic rate and reverses dietary and leptin-deficient diabetes. Endocrinology Jun 2004, 145:2594-2603.
198. Kharitonenkov A., Shiyanova T.L., Koester A., et al. FGF-21 as a novel metabolic regulator. J Clin Invest Jun 2005, 115:1627-1635.
199. Takagi Y., Takahashi J., Saiki H., et al. Dopaminergic neurons generated from monkey embryonic stem cells function in a Parkinson primate model. J Clin Invest Jan 2005, 115:102-109.
200. Hebert J.M., Rosenquist T., Gotz J., Martin G.R. FGF5 as a regulator of the hair growth cycle: evidence from targeted and spontaneous mutations. Cell Sep 23 1994, 78:1017-1025.
201. Coutu D.L., Galipeau J. Roles of FGF signaling in stem cell self-renewal, senescence and aging. Aging (Albany NY) Oct 2011, 3:920-933.